Kazuno Omori
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Lipotoxicity Induces β-cell Small Extracellular Vesicle-Mediated β-cell Dysfunction in Male Mice.
Journal: Endocrinology
Published: September 15, 2024
Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease.
Journal: Diabetes & metabolism journal
Published: October 15, 2023
Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study.
Journal: Diabetes research and clinical practice
Published: July 29, 2022
The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetes.
Journal: Geriatrics & gerontology international
Published: November 02, 2021
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.
Journal: Diabetes, obesity & metabolism
Published: July 29, 2021
Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study).
Journal: Diabetes research and clinical practice
Published: July 06, 2021
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Journal: Diabetes, obesity & metabolism
Published: March 16, 2021
Severe infection including disseminated herpes zoster triggered by subclinical Cushing's disease: a case report.
Journal: BMC endocrine disorders
Published: January 26, 2021
Glucokinase is required for high-starch diet-induced β-cell mass expansion in mice.
Journal: Journal of diabetes investigation
Published: October 23, 2020
Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin.
Journal: Journal of diabetes investigation
Published: September 29, 2020
Favorable effect of sodium-glucose cotransporter 2 inhibitor, dapagliflozin, on non-alcoholic fatty liver disease compared with pioglitazone.
Journal: Journal of diabetes investigation
Published: September 10, 2020
Last Updated: 09/26/2026